ライフサイエンスコーパス: scintillation proximity assay

1 ified biochemically with a cytosol-dependent scintillation proximity assay.

2 y were determined using this FP method and a scintillation proximity assay.

3 rsible loss of ligand binding as assessed by scintillation proximity assay.

4 rs of human DNA topoisomerase I based on the scintillation proximity assay.

5 (3)H]troglitazone, a PPARgamma agonist, in a scintillation proximity assay.

6 ration calorimetry, equilibrium dialysis and scintillation proximity assays.

7 nding and peptide-myristoylation activity in scintillation proximity assays.

8 e use of AMP-PCP coupled with the use of the scintillation proximity assay allows this characterizati

9 high-throughput screening, are described: a scintillation proximity assay and a time-resolved fluore

10 We have developed a cell-free and scintillation-proximity assay-based screen to search for

11 cts by immobilization on streptavidin-coated scintillation proximity assay beads.

12 rmat described is called an aaRS competitive scintillation proximity assay (cSPA).

13 Scintillation proximity assays designed to look at the b

14 method described here is the first reported scintillation proximity assay for a peroxisome prolifera

15 A scintillation proximity assay for measurement of 3H-radi

16 A scintillation proximity assay for peroxisome proliferato

17 (50) values obtained by FP binding assay and scintillation proximity assay for the clinically used PP

18 The molecule exhibits activity in a scintillation-proximity assay for the inhibition of the

19 assay for acetyl CoA carboxylase (ACC) in a scintillation proximity assay format suitable for high-t

20 To our knowledge this ACC/FAS coupled scintillation proximity assay is the only assay format t

21 PAR ligands obtained in FP binding assay and scintillation proximity assay or gel filtration binding

22 Identified "hits" were then confirmed in a scintillation proximity assay (SPA) and a DEAE membrane-

23 neous proximity assays for tyrosine kinases, scintillation proximity assay (SPA) and homogeneous time

24 e obtained from the conventional assay using scintillation proximity assay (SPA) beads and a scintill

25 By using wheat germ agglutinin (WGA)-coated scintillation proximity assay (SPA) beads to capture 125

26 mer was immobilized onto streptavidin-coated scintillation proximity assay (SPA) beads, and after add

27 We describe the first validated scintillation proximity assay (SPA) binding method for q

28 Here we report the development of a coupled scintillation proximity assay (SPA) for 3 KDMs: KDM1A (L

29 A homogeneous scintillation proximity assay (SPA) for detection of RNA

30 hput, we have developed a novel, homogeneous scintillation proximity assay (SPA) for DGAT.

31 We have developed a novel 96-well plate scintillation proximity assay (SPA) for measuring small

32 A simple, high-throughput scintillation proximity assay (SPA) for parathyroid horm

33 using biotinylated NAD, we have developed a scintillation proximity assay (SPA) for PARP.

34 Here we report a 96-well homogeneous scintillation proximity assay (SPA) for the study of Dna

35 stone deacetylase assay that is based on the scintillation proximity assay (SPA) principle.

36 fatty acid amide hydrolase (FAAH) using the scintillation proximity assay (SPA) technology is descri

37 , and homogeneous binding assay based on the scintillation proximity assay (SPA) technology that prov

38 o previously reported procedures: the use of scintillation proximity assay (SPA) technology to measur

39 (RPA) with the quantification advantages of scintillation proximity assay (SPA) technology.

40 H2 domain with a phosphopeptide ligand using scintillation proximity assay (SPA) technology.

41 We have developed a quantitative scintillation proximity assay (SPA) that reproduces the

42 We have adapted and optimized a scintillation proximity assay (SPA) to replace the more

43 A scintillation proximity assay (SPA) using 33phosphorous

44 A scintillation proximity assay (SPA) was developed to det

45 tosaminyltransferase (GalNAc-transferase) by scintillation proximity assay (SPA) was developed.

46 We have developed a scintillation proximity assay (SPA) where use of biotiny

47 de triphosphatase activity was measured in a scintillation proximity assay (SPA)-based high-throughpu

48 metal ion affinity chromatography (IMAC) and scintillation proximity assay (SPA).

49 es than on DNA-core-trimmed nucleosomes in a scintillation proximity assay (SPA).

50 ter-binding format or by a novel homogeneous scintillation proximity assay (SPA).

51 In combination with the scintillation proximity assay (SPA[trade]), this allows

52 We developed scintillation proximity assays (SPA) to discover compoun

53 d the purified DII S1-S4 protein to create a scintillation proximity assay suitable for high-throughp

54 roduct is then directly quantified using the scintillation proximity assay technology: binding of the

55 distinct inhibitory profile, we developed a scintillation proximity assay that permits analysis of r

56 The screen uses a scintillation proximity assay to identify compounds that

57 The soluble receptor was used in a scintillation proximity assay to identify two chemical c

58 We now describe a scintillation proximity assay to measure soluble inosito

59 try of the targeting process, we developed a scintillation proximity assay to study the stepwise asso

60 Using the antibody-capture [(35)S]GTPgammaS scintillation proximity assay, we demonstrated for the f

61 format for the detection of inhibition is a scintillation proximity assay which is robust and reprod